DE60231427D1 - Antivirale, antibakterielle pharmazeutische zusammensetzung von cantharidinanhydrid und herstellungsverfahren dafür - Google Patents

Antivirale, antibakterielle pharmazeutische zusammensetzung von cantharidinanhydrid und herstellungsverfahren dafür

Info

Publication number
DE60231427D1
DE60231427D1 DE60231427T DE60231427T DE60231427D1 DE 60231427 D1 DE60231427 D1 DE 60231427D1 DE 60231427 T DE60231427 T DE 60231427T DE 60231427 T DE60231427 T DE 60231427T DE 60231427 D1 DE60231427 D1 DE 60231427D1
Authority
DE
Germany
Prior art keywords
essential oil
cantharidic anhydride
antiviral
pharmaceutical composition
cantharidinanhydride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60231427T
Other languages
English (en)
Inventor
Wei Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60231427D1 publication Critical patent/DE60231427D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
DE60231427T 2001-11-23 2002-11-22 Antivirale, antibakterielle pharmazeutische zusammensetzung von cantharidinanhydrid und herstellungsverfahren dafür Expired - Lifetime DE60231427D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB011400668A CN1190190C (zh) 2001-11-23 2001-11-23 一种抗病毒、抗菌的斑蝥酸酐药物组合物及其制备方法
PCT/CN2002/000839 WO2003043623A1 (fr) 2001-11-23 2002-11-22 Compositions pharmaceutiques antivirales, antibacteriennes d'anhydride cantharidique et son procede de preparation

Publications (1)

Publication Number Publication Date
DE60231427D1 true DE60231427D1 (de) 2009-04-16

Family

ID=4675631

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60231427T Expired - Lifetime DE60231427D1 (de) 2001-11-23 2002-11-22 Antivirale, antibakterielle pharmazeutische zusammensetzung von cantharidinanhydrid und herstellungsverfahren dafür

Country Status (7)

Country Link
US (1) US8003691B2 (de)
EP (1) EP1454624B1 (de)
CN (1) CN1190190C (de)
AT (1) ATE424212T1 (de)
AU (1) AU2002349451A1 (de)
DE (1) DE60231427D1 (de)
WO (1) WO2003043623A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021238836A1 (zh) * 2020-05-25 2021-12-02 甘肃芫美药业有限公司 一种斑蝥素抗病毒、抗菌制剂、其制备方法及用作预防和治疗新冠病毒感染

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL281225A (de) * 1961-07-20
US4678664A (en) * 1982-09-30 1987-07-07 Basf Corporation Mineral oil gels
DE3821553A1 (de) 1988-06-22 1989-12-28 Schering Ag Substituierte n-phenyl-4-alkyliden-1,3-oxathiolan-2-imine, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider wirkung
FR2655223B1 (fr) * 1989-11-27 1992-02-07 Cit Alcatel Procede de gestion des flux dans un reseau numerique de telecommunication a integration de services, a large bande, et reseau pour le mise en óoeuvre de ce procede.
CN1029771C (zh) * 1990-08-29 1995-09-20 王日卫 斑蝥素脂溶性制剂的制备
CN1036046C (zh) * 1991-12-10 1997-10-08 王日卫 斑蝥素脂溶性制剂的制备
JPH05255367A (ja) * 1992-02-28 1993-10-05 Jitsuei O カンタリジン誘導体組成物の製造法及びそれを含む抗ウイルス剤
CN1076111A (zh) * 1992-03-11 1993-09-15 王日卫 斑蝥酸盐抗病毒制剂及其制备
JP3834080B2 (ja) * 1994-08-12 2006-10-18 英介 後藤 蛋白質脱リン酸化酵素阻害剤を主成分とする未成熟凝縮染色体生成剤と生成方法
CN1039588C (zh) * 1995-03-29 1998-08-26 邹娟 新的抗肿瘤铂络合物
EP0956859B1 (de) * 1996-09-27 2006-03-15 Takeshi Karita Antioxidierende zusammenstellung zum abfangen von freien radikalen, arzneimittel, welche diese umfasst und verfahren zu deren herstelling
US6114348A (en) * 1999-03-10 2000-09-05 Weber; Paul J. Method of treating warts using tazarotene
RS49778B (sr) * 2000-06-15 2008-06-05 Ad. "Zdravlje" Farmaceutsko-Hemijska Industrija, FARMACEUTSKI DEZINFEKCIONI PREPARAT NA BAZI Na-USNINATA I LEKOVITOG BILJA I POSTUPAK ZA NJIHOVO DOBIJANJE
CN1166669C (zh) * 2002-03-20 2004-09-15 贵州君之堂制药有限公司 斑蝥酸钠的制备工艺

Also Published As

Publication number Publication date
CN1190190C (zh) 2005-02-23
US20050070600A1 (en) 2005-03-31
EP1454624A1 (de) 2004-09-08
US8003691B2 (en) 2011-08-23
ATE424212T1 (de) 2009-03-15
EP1454624B1 (de) 2009-03-04
WO2003043623A1 (fr) 2003-05-30
EP1454624A4 (de) 2006-05-31
AU2002349451A1 (en) 2003-06-10
CN1421202A (zh) 2003-06-04

Similar Documents

Publication Publication Date Title
GEP20104960B (en) USE OF [D-MeALa]3-[EtVal]4-CYCLOSPORIN FOR THE TREATMENT OF HEPATITIS C INFECTION AND PHARMACEUTICAL COMPOSITION COMPRISING SAID [D-MeAla]3-[EtVal]4-CYCLOSPORIN
ATE504579T1 (de) Antivirale mittel
UY27333A1 (es) Nucleótidos 4` sustituidos
DE60215157D1 (de) Verwendungen von antiviralen nucleosid-derivaten zur herstellung eines medikaments zur behandlung von hepatitis c infektionen
WO2003051306A3 (en) N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
NZ610715A (en) Antiviral compounds and methods
BR9710355A (pt) Composição útil para o tratamento de infecções virais em um mamìfero, processo para tratar uma infecção viral em um mamìfero, e, produto medicinal.
IL143512A (en) Azabicycloalkanes, pharmaceuticals including them and their use in the manufacture of drugs for the prevention or treatment of infection by the immunodeficiency virus
SV2005001920A (es) " compuestos nucleosidos para el tratamiento de infecciones virales "
CR8273A (es) Administracion de ligandos de tlr7 y profarmacos de los mismos para el tratamiento de la infeccion por el virus de hepetitis c
HUP0001379A2 (hu) Készítmény humán immundeficiencia vírus és más vírusfertőzések okozta betegségek antimikrobás megelőzésére és kezelésére
WO2004071426A3 (en) Compounds for the treatment of viral infection
BR0110023A (pt) Derivados de nucleosìdeo 3'-ou-2' substituìdos para tratamento de infecções por vìrus da hepatite
WO2007038507A3 (en) Modified 4'-nucleosides as antiviral agents
RU94002475A (ru) Фармацевтическая композиция и ее применение для лечения вирусных инфекций
WO2005095345A3 (en) Heteroaryl guanidines as inhibitors of viral replication
HUP0202502A2 (hu) Virális fertőzőképességet blokkoló peptidek és eljárások ezek alkalmazására
WO2005084315A3 (en) Pyranoindole derivatives and the use thereof for the treatment of hepatitis c virus infection or disease
JP2006507295A5 (de)
WO2005076001A3 (en) A polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual
EP1655292A4 (de) Präventive bzw. therapeutische zusammensetzung gegen virale infektionskrankheiten
BRPI0407140A (pt) Droga terapêutica para vìrus
GEP20084377B (en) Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections
WO2001097824A3 (de) Verwendung von phyllanthusbestandteilen zur behandlung oder prophylaxe von infekten durch flaviviridae
WO2007098247A3 (en) Substituted taraxastanes useful for treating viral infections

Legal Events

Date Code Title Description
8364 No opposition during term of opposition